Paul Mischel
Pathology / Anatomic Pathology & Clinical Pathology
Credentials: · · ·
History
Pathology-Anatomic and Clinical
Research
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Nature Medicine · 2007 · 1,152 citations
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
New England Journal of Medicine · 2005 · Last of 24 authors · 1,134 citations
High-throughput oncogene mutation profiling in human cancer
Nature Genetics · 2007 · 844 citations
91 papers
44 papers
44 papers
28 papers
28 papers
- IM
22 papers
21 papers · 1 as a fellow
20 papers · 3 as a fellow
Grants
- 2022–2027
- 2021–2026
Integrated Ligand and Target Discovery by Chemical Proteomics for Glioblastoma Treatment.
National Cancer Institute · R01
Contact PI · $3.3M · Stanford University
- 2011–2022
The Role of mTORC2 in Reprogramming Cancer Cell Metabolism
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $3.4M · Stanford University
- 2010–2016
Nanosystems Biology Cancer Center 2
National Cancer Institute · U54
Project lead · $1.8M · California Institute of Technology